The Impact of COVID-19 and Vaccine on the Human Nervous System
- PMID: 35316815
- PMCID: PMC9148879
- DOI: 10.1159/000524234
The Impact of COVID-19 and Vaccine on the Human Nervous System
Abstract
The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has precipitated a global health crisis of unprecedented proportions. Due to its severe impact, multiple COVID-19 vaccines are being developed, approved, and manufactured rapidly. However, some serious adverse events (AEs) were reported after the application of them, significantly increasing concerns about the safety and efficacy of the vaccines and doubts about the necessity of vaccination. Particularly, previous vaccination campaigns have shown us that partial vaccination can induce neurologic AEs. Herein, we discuss in depth the involvement of the nervous system during SARS-CoV-2 infection or after vaccination. On the one hand, COVID-19 could pose an enormous threat to human neurological health through direct infection and indirect neurotoxicity effects. On the other hand, our review indicated that only a few serious neurological AEs following vaccination occurred and among which headache was the most common. Moreover, some neurological AEs do not seem to be related to vaccination. Of course, the causal relationships between several vaccines and AEs are considered plausible, and it is not doubtful that these AEs should be taken seriously by clinicians in assessing the potential risks and benefits of vaccinations in special populations. Nevertheless, in the case of the rapid spread of COVID-19, the potential side effects of vaccination on the nervous system should be compared with adverse COVID-19 outcomes rather than being considered alone. Thus, it is obviously a wise option to be vaccinated instead of suffering from serious adverse symptoms of virus infection.
Keywords: AZD1222; Bell’s palsy; COVID-19 vaccines; Guillain-Barré syndrome; Neurological adverse events; Severe acute respiratory syndrome coronavirus 2; mRNA vaccine.
© 2022 S. Karger AG, Basel.
Similar articles
-
The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNFα blockade.J Med Virol. 2022 Dec;94(12):5780-5789. doi: 10.1002/jmv.28063. Epub 2022 Aug 19. J Med Virol. 2022. PMID: 35945627 Free PMC article.
-
Effects of COVID-19 and mRNA vaccines on human fertility.Hum Reprod. 2021 Dec 27;37(1):5-13. doi: 10.1093/humrep/deab238. Hum Reprod. 2021. PMID: 34734259 Free PMC article.
-
Antibody and T-cellular response to COVID-19 booster vaccine in SARS-CoV-1 survivors.Clin Immunol. 2022 Nov;244:109103. doi: 10.1016/j.clim.2022.109103. Epub 2022 Aug 29. Clin Immunol. 2022. PMID: 36049602 Free PMC article.
-
[Expert recommendations on human papillomavirus vaccine immunization strategies in China].Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Sep 6;56(9):1165-1174. doi: 10.3760/cma.j.cn112150-20220505-00443. Zhonghua Yu Fang Yi Xue Za Zhi. 2022. PMID: 36207876 Review. Chinese.
-
Neurological manifestations associated with COVID-19 vaccine.Neurologia (Engl Ed). 2025 Jan-Feb;40(1):66-76. doi: 10.1016/j.nrleng.2022.09.007. Epub 2022 Oct 23. Neurologia (Engl Ed). 2025. PMID: 36288776 Free PMC article. Review.
Cited by
-
Bibliometric analysis of publication trends and topics of influenza-related encephalopathy from 2000 to 2022.Immun Inflamm Dis. 2023 Sep;11(9):e1013. doi: 10.1002/iid3.1013. Immun Inflamm Dis. 2023. PMID: 37773718 Free PMC article.
-
Exploring the multifaceted potential of (R)-ketamine beyond antidepressant applications.Front Pharmacol. 2024 Apr 11;15:1337749. doi: 10.3389/fphar.2024.1337749. eCollection 2024. Front Pharmacol. 2024. PMID: 38666026 Free PMC article. Review.
References
-
- World Health Organization WHO Coronavirus disease (COVID19) dashboard. 2022. Available from: https://covid19.who.int/
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous